Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1MIGLUSTAT
(Zavesca (TN))
1件: Miglustat (Zavesca)1件: Miglustat (Zavesca (TN)) 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299 💬
2Miglustat (AT2221)
(Zavesca (TN))
1件: Miglustat (Zavesca)1件: Miglustat (Zavesca (TN)) 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 256 💬
3MIGLUSTAT (ZAVESCA)1件: Miglustat (Zavesca)1件: Miglustat (Zavesca (TN)) 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
4ZAVESCA1件: Miglustat (Zavesca)1件: Miglustat (Zavesca (TN)) 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299 💬
5Zavesca (Miglustat)1件: Miglustat (Zavesca)1件: Miglustat (Zavesca (TN)) 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
6ZAVESCA 84CPS 100MG1件: Miglustat (Zavesca)1件: Miglustat (Zavesca (TN)) 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
7Zavesca® Prescription1件: Miglustat (Zavesca)1件: Miglustat (Zavesca (TN)) 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 256 💬